Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer

BJU International

Volumn 121, Issue 4, 2018, Pages 534-539

  Parsons, J Kellogg ^a,b,c   Pierce, John P ^d   Mohler, James ^e   Paskett, Electra ^f   Jung, Sin Ho ^g   Morris, Michael J ^h   Small, Eric ⁱ   Hahn, Olwen ^j   Humphrey, Peter ^k   Taylor, John ^e   Marshall, James ^e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g DUKE UNIVERSITY   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

PCSM; ProstateCancer; active surveillance; carotenoids; diet; outcomes; prevention

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; ASIAN AMERICAN; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER LOCALIZATION; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DIET THERAPY; ETHNICITY; FEASIBILITY STUDY; GEOGRAPHIC DISTRIBUTION; GLEASON SCORE; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COUNSELING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; RANDOMIZED CONTROLLED TRIAL; VALIDITY; VEGETABLE; BIOPSY; BLOOD; CLINICAL TRIAL; DIET; DISEASE EXACERBATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

PROSTATE SPECIFIC ANTIGEN;

AGED; AGED, 80 AND OVER; BIOPSY; DIET; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; VEGETABLES;

EID: 85019855963     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13890     Document Type: Article

References (25)

1. Bul M, Zhu X, Valdagni R et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 2013; 63: 597–603
2. Klotz L, Vesprini D, Sethukavalan P et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 2015; 33: 272–7
3. Tosoian JJ, Trock BJ, Landis P et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 2011; 29: 2185–90
4. Welty CJ, Cowan JE, Nguyen H et al. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol 2015; 193: 807–11
5. Newcomb LF, Thompson IM Jr, Boyer HD et al. Outcomes of active surveillance for clinically localized prostate cancer in the prospective, multi-institutional canary PASS cohort. J Urol 2016; 195: 313–20
6. Fleshner NE, Lucia MS, Egerdie B et al. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 1103–11
7. Hamilton Z, Parsons JK. Prostate cancer prevention: concepts and clinical trials. Curr Urol Rep 2016; 17: 35
8. Richman EL, Kenfield SA, Chavarro JE et al. Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med 2013; 173: 1318–26
9. Frattaroli J, Weidner G, Dnistrian AM et al. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 2008; 72: 1319–23
10. Richman EL, Carroll PR, Chan JM. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer 2012; 131: 201–10
11. Barber NJ, Zhang X, Zhu G et al. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis 2006; 9: 407–13
12. Brooks JD, Paton VG, Vidanes G. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 2001; 10: 949–54
13. Nordstrom T, Van Blarigan EL, Ngo V et al. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate 2016; 76: 339–48
14. Liu B, Mao Q, Cao M, Xie L. Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis. Int J Urol 2012; 19: 134–41
15. Zu K, Mucci L, Rosner BA et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst 2014; 106: djt430
16. Parsons JK, Newman V, Mohler JL et al. The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer. Urology 2008; 72: 633–7
17. Parsons JK, Newman VA, Mohler JL, Pierce JP, Flatt S, Marshall J. Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study. BJU Int 2008; 101: 1227–31
18. Parsons JK, Pierce JP, Mohler J et al. A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]). Contemp Clin Trials 2014; 38: 198–203
19. Bang H, Jung SH, George SL. Sample size calculation for simulation-based multiple-testing procedures. J Biopharm Stat 2005; 15: 957–67
20. Leapman MS, Freedland SJ, Aronson WJ et al. Pathologic and biochemical outcomes among African-American and caucasian men with low-risk prostate cancer in the SEARCH database: implications for active surveillance candidacy. J Urol 2016; 196: 1408–14
21. Sundi D, Faisal FA, Trock BJ et al. Reclassification rates are higher among African American men than Caucasians on active surveillance. Urology 2015; 85: 155–60
22. Ornish D, Weidner G, Fair WR et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005; 174: 1065–9
23. Ornish D, Lin J, Chan JM et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 2013; 14: 1112–20
24. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990-2013. JAMA 2015; 314: 80–2
25. Womble PR, Montie JE, Ye Z et al. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. Eur Urol 2015; 67: 44–50